Results 21 to 30 of about 1,115 (179)

Evaluation of the safety and efficacy of extracorporeal carbon dioxide removal in the critically ill using the PrismaLung+ device

open access: yesEuropean Journal of Medical Research, 2023
Background Several extracorporeal carbon dioxide removal (ECCO2R) devices are currently in use with variable efficacy and safety profiles. PrismaLung+ is an ECCO2R device that was recently introduced into clinical practice.
Ravindranath Tiruvoipati   +6 more
doaj   +2 more sources

ECCO2R as a bridge to a decision in type II respiratory failure

open access: yesActa Medica Lituanica, 2019
Introduction. End-of-life decisions are often time consuming and difficult for everyone involved. In some of these cases extracorporeal life support systems could potentially be used not only as a bridge to treatment but as a tool to buy time to allow ...
Lina Grauslytė   +2 more
doaj   +4 more sources

Low-flow assessment of current ECMO/ECCO2R rotary blood pumps and the potential effect on hemocompatibility [PDF]

open access: yesCritical Care, 2019
Background Extracorporeal carbon dioxide removal (ECCO2R) uses an extracorporeal circuit to directly remove carbon dioxide from the blood either in lieu of mechanical ventilation or in combination with it.
Sascha Gross-Hardt   +7 more
doaj   +2 more sources

Low-flow ECCO2R conjoined with renal replacement therapy platform to manage pulmonary vascular dysfunction with refractory hypercapnia in ARDS

open access: yesHeliyon
Background: Hypercapnia worsens lung vascular dysfunction during acute respiratory distress syndrome (ARDS). We tested whether an extracorporeal carbon dioxide removal (ECCO2R) device based on a renal replacement therapy platform (Prismalung®) may reduce
Armand Mekontso Dessap   +7 more
doaj   +2 more sources

Evaluation of Plasma Biomarkers to Understand the Biology and Heterogeneity of Treatment Effect in Lower Tidal Volume Ventilation Facilitated by Extracorporeal CO2 Removal in Acute Hypoxemic Respiratory Failure: A Secondary Analysis of the REST Trial [PDF]

open access: yesCritical Care Explorations
OBJECTIVES:. In patients with acute hypoxemic respiratory failure (AHRF), the use of lower tidal volume ventilation facilitated by veno-venous extracorporeal CO2 removal (vv-ECCO2R) does not improve clinical outcomes.
Andrew J. Boyle, PhD   +17 more
doaj   +2 more sources

An extracorporeal carbon dioxide removal (ECCO2R) device operating at hemodialysis blood flow rates

open access: yesIntensive Care Medicine Experimental, 2017
Background Extracorporeal carbon dioxide removal (ECCO2R) systems have gained clinical appeal as supplemental therapy in the treatment of acute and chronic respiratory injuries with low tidal volume or non-invasive ventilation. We have developed an ultra-
R. Garrett Jeffries   +3 more
doaj   +2 more sources

Extracorporeal carbon dioxide removal for patients with acute respiratory failure: a systematic review and meta-analysis

open access: yesAnnals of Medicine, 2023
Background Acute respiratory failure (ARF) is a common clinical critical syndrome with substantial mortality. Extracorporeal carbon dioxide removal (ECCO2R) has been proposed for the treatment of ARF.
Zhifeng Zhou   +5 more
doaj   +1 more source

Focus on ECMO and ECCO2R in ARDS patients [PDF]

open access: yesIntensive Care Medicine, 2017
no ...
Bein, Thomas   +2 more
openaire   +4 more sources

A preliminary cost-effectiveness analysis of lung protective ventilation with extra corporeal carbon dioxide removal (ECCO2R) in the management of acute respiratory distress syndrome (ARDS). [PDF]

open access: yes, 2021
peer reviewed[en] BACKGROUND: Mechanical ventilation (MV) is the cornerstone in the management of the acute respiratory distress syndrome (ARDS). Recent research suggests that decreasing the intensity of MV using lung protective ventilation (LPV) with ...
Quintel, Michael   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy